1-4 of 4
Jin-Song Jia
Close
Sort by
Journal Articles

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Feifei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Zhao Ting, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4288.
https://doi.org/10.1182/blood-2023-188657
Published: 2023
Journal Articles

Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Wen-Jing Yu, Ying Wu, Qi Chen, Xiaolu Zhu, Xu-Ying Pei, Jin-Song Jia, Jing Wang, Xiao-Su Zhao, Ying-Jun Chang, Yue-Yun Lai, Hong-Xia Shi, Guo-Rui Ruan, Ya-Zhen Qin, Xiao-Hong Liu, Xiao Jun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1525.
https://doi.org/10.1182/blood-2023-184665
Published: 2023
Journal Articles

MED16 Negatively Regulates Erythropoiesis and Myelopoiesis through Modulation of Chromatin Accessibility

Sera Xie, Fan Wu, Xinying Zhao, Qiuyu Yue, Shicong Zhu, Ling-Hui Yan, Yuan Zhou, Tong Xing, Qi Hu, Dong Li, Jin-Song Jia, Yuan Kong, Xiao-Jun Huang, Xiaofei Gao, Hsiang-Ying Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 2673.
https://doi.org/10.1182/blood-2023-189650
Published: 2023
Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Clinical Trials & Observations
Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai
Journal: Blood
Blood (2018) 131 (26): 2987–2989.
https://doi.org/10.1182/blood-2018-02-834051
Published: 2018
Includes: Supplemental data